Americas & Europe Tendinitis Market Overview
Tendinitis is that the inflammation of the tendon, thick cords that attache the muscles to the bone. The inflammation happens as a results of sudden injury to the tendon, repetitive movement or disease condition like polygenic disorder, reiter's syndrome, gout, Reiter's disease or lupus. just in case of patients with diabetes, the uric acid crystals within the gout tendon sheath resulting in friction. tendinitis is found to be prevalent among athletes and is one among the common sport injuries in sport players, especially court game, golf et al.. various pharmacologic and non-pharmacological treatments are offered for the treatment of tendinitis. Non-Steroidal anti-inflammatory medicine (NSAIDs) represent the preliminary treatment choices. alternative treatments as well as physical therapy, rest, and occupational therapy. Surgery is that the expedient for tendinitis, and is merely suggested just in case of severe damage to the sinew that can't be treated victimisation pharmacological treatment choices.
The market for tendinitis treatment is expected to grow at an exponential rate due to increasing prevalence of sports injuries, rising geriatric population, increasing prevalence of patients suffering from diabetes and rheumatoid arthritis. facet effects of the treatment i.e. use of NSAIDs resulting in stomach upset, and gastrointestinal (GI) bleeding.
Report Metric |
Details |
Market size available for years |
2023–2030 |
Base year considered |
2023 |
Forecast period |
2024–2030 |
Forecast unit |
Value (USD Million) |
Segments covered |
Type, Treatment, End User, and Region |
Regions covered |
North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
Companies covered |
Abbott Laboratories, Merck & Co. Inc., Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline plc., Pfizer Inc., Bayer, Teva Pharmaceutical Industries, AstraZeneca. |
The covid-19 Impact on Americas & Europe Tendinitis Market:
Like several different industries, COVID-19 badly knocked the electronic and semiconductor trade. This new event has compact nearly 230 countries in exactly a couple of weeks, leading to the forced conclusion of producing and transportation activities at intervals and across the countries. This has directly affected the expansion of the sector. It's calculable that COVID-19 to depart over USD thirty billion impacts on the physics and semiconductor trade. The arena is majorly affected thanks to transport restrictions on major physics and semiconductor staple suppliers. However, the rising want for semiconductors in many industries can supply fast market recovery over the longer-term amount.
Americas & Europe Tendinitis Market Segment Overview

By Type, On the basis of type, the market is segmented into Achilles tendinitis, supraspinatus tendinitis, lawn tennis or golfer's elbow, de Quervain's tenosynovitis, and others.
By Treatment, On the basis of treatment, the market is segmented into designation, therapy, shock wave therapy or surgery, medical devices, devices, and others.Diagnosis is further segmental into physical examination, imaging tests, ultrasound, magnetic resonance Imaging (MRI) Scans, and others.
On the basis of end user, the market is segmented into hospitals & clinics, medical analysis centers, academic institutes, and others.
Market Analysis, Insights and Forecast – By Type
· Achilles Tendinitis
· Supraspinatus Tendinitis
· Tennis or Golfers Elbow
· De Quervains Tenosynovitis
Market Analysis, Insights and Forecast – By Treatment
· Diagnosis Therapy
· Shock Wave Therapy or Surgery
· Medical Devices
· Devices
· Others.
Market Analysis, Insights and Forecast – By End User
· Hospitals & Clinics
· Medical Research Centers
· Academic Institutes
Americas & Europe Tendinitis Market Regional Overview
Region-wise, in terms of regions, American region is that the major market for tendonitis treatment attributable to rise in prevalence of sport injuries & malady like arthritis and increase in demand for new treatment choices for tendinitis within the region. European region is predicted to witness higher growth rate because of increase in accessibility of funds for research and development (R&D) activities in medical devices and rise in prevalence of diabetes & rheumatoid arthritis over the forecast amount.
Americas & Europe Tendinitis Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Americas & Europe Tendinitis Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Americas & Europe Tendinitis are highlighted below.
· In April 2018 – Samumed, LLC (US), a leader in Wnt analysis and development presented its latest preclinical and clinical data on the company’s investigational Wnt pathway inhibitors for the treatment of degenerative joint disease (SM04690) and tendinopathy (SM04755) at the 2018 osteoarthritis analysis Society International World Congress in urban center, U.K.
Americas & Europe Tendinitis Market, Key Players
· Abbott Laboratories
· Merck & Co. Inc.
· Boehringer Ingelheim Pharmaceuticals, Inc.
· GlaxoSmithKline plc.
· Pfizer Inc.
· Bayer
· Teva Pharmaceutical Industries
· AstraZeneca.
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Americas & Europe Tendinitis market during the forecast period?
Americas & Europe Tendinitis market is expected to record a CAGR of ~ 3.9 % during the forecast period.
Q2. Which segment is projected to hold the largest share in the Americas & Europe Tendinitis Market?
Hospital and Clinics segment is projected to hold the largest share in the Americas & Europe Tendinitis Market.
Q3. What are the driving factors for the Americas & Europe Tendinitis market?
The growing global geriatric population is liable to tendonitis or might be stricken by bone disorders, osteoporosis, rheumatoid arthritis, diabetes, and osteoarthritis. Constant innovation of technologies and therapies in treating rubor is causative to the expansion. confirmatory government initiatives and vital investments and collaborations amongst key players to expand product offerings are key factors that boost the growth of the Americas & Europe Tendinitis market progressively.
Q4. Which Segments are covered in the Americas & Europe Tendinitis market report?
Type, Treatment,End User, and Region, these segments are covered in the Americas & Europe Tendinitis market report
Q5. Which are the prominent players offering Americas & Europe Tendinitis?
Abbott Laboratories,Merck & Co. Inc.,Boehringer Ingelheim Pharmaceuticals, Inc.,GlaxoSmithKline plc.,Pfizer Inc.,Bayer,Teva Pharmaceutical Industries,AstraZeneca.
List of Figures
Figure 1: Global Americas & Europe Tendinitis Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Americas & Europe Tendinitis Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Americas & Europe Tendinitis Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Americas & Europe Tendinitis Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Americas & Europe Tendinitis Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Americas & Europe Tendinitis Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Americas & Europe Tendinitis Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Americas & Europe Tendinitis Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Americas & Europe Tendinitis Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Americas & Europe Tendinitis Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Americas & Europe Tendinitis Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Americas & Europe Tendinitis Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Americas & Europe Tendinitis Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Americas & Europe Tendinitis Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Americas & Europe Tendinitis Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Americas & Europe Tendinitis Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Americas & Europe Tendinitis Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Americas & Europe Tendinitis Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Americas & Europe Tendinitis Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Americas & Europe Tendinitis Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Americas & Europe Tendinitis Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Americas & Europe Tendinitis Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Americas & Europe Tendinitis Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Americas & Europe Tendinitis Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Americas & Europe Tendinitis Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Americas & Europe Tendinitis Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Research Process
Data Library Research are conducted by industry experts who offer insight on
industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager
and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary Research
Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size Estimation
Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model